125 related articles for article (PubMed ID: 18332829)
1. Early use of allograft skin: are 3-day microbiologic cultures safe?
Britton-Byrd BW; Lynch JP; Williamson S; McCauley RL
J Trauma; 2008 Mar; 64(3):816-8. PubMed ID: 18332829
[TBL] [Abstract][Full Text] [Related]
2. Blood and marrow cultures as indicators of bone contamination in cadaver donors.
Martinez OV; Buck BE; Hernandez M; Malinin T
Clin Orthop Relat Res; 2003 Apr; (409):317-24. PubMed ID: 12671517
[TBL] [Abstract][Full Text] [Related]
3. Bacterial contamination of tissue allografts - experiences of the donor tissue bank of Victoria.
Ireland L; Spelman D
Cell Tissue Bank; 2005; 6(3):181-9. PubMed ID: 16151958
[TBL] [Abstract][Full Text] [Related]
4. The use of allograft bone in spine surgery: is it safe?
Mroz TE; Joyce MJ; Lieberman IH; Steinmetz MP; Benzel EC; Wang JC
Spine J; 2009 Apr; 9(4):303-8. PubMed ID: 18805063
[TBL] [Abstract][Full Text] [Related]
5. Cadaveric allograft discards as a result of positive skin cultures.
Obeng MK; McCauley RL; Barnett JR; Heggers JP; Sheridan K; Schutzler SS
Burns; 2001 May; 27(3):267-71. PubMed ID: 11311520
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of skin allograft discards as a result of serological and molecular microbiological screening in a regional skin bank in Italy.
Pianigiani E; Risulo M; Ierardi F; Sbano P; Andreassi L; Fimiani M; Caudai C; Valensin PE; Zazzi M
Burns; 2006 May; 32(3):348-51. PubMed ID: 16529868
[TBL] [Abstract][Full Text] [Related]
7. Processing efficacy in relation to microbial contamination of skin allografts from 723 donors.
Pianigiani E; Ierardi F; Cuciti C; Brignali S; Oggioni M; Fimiani M
Burns; 2010 May; 36(3):347-51. PubMed ID: 19616385
[TBL] [Abstract][Full Text] [Related]
8. A 14-Year Audit and Analysis of Human Skin Allograft Discards.
Spradbrow J; Etchells M; Cartotto R; Halliday A; Lin Y; Simor A; Visvalingam R; Callum J
J Burn Care Res; 2017; 38(5):e786-e795. PubMed ID: 28045778
[TBL] [Abstract][Full Text] [Related]
9. Use of skin allograft and its donation rate in Singapore: an 11-year retrospective review for burns treatment.
Chua A; Song C; Chai A; Kong S; Tan KC
Transplant Proc; 2007 Jun; 39(5):1314-6. PubMed ID: 17580129
[TBL] [Abstract][Full Text] [Related]
10. Identification of the optimal donor quality scoring system and measure of early renal function in kidney transplantation.
Moore J; Ramakrishna S; Tan K; Cockwell P; Eardley K; Little MA; Rylance P; Shivakumar K; Suresh V; Tomlinson K; Ready A; Borrows R
Transplantation; 2009 Feb; 87(4):578-86. PubMed ID: 19307797
[TBL] [Abstract][Full Text] [Related]
11. Allograft update: the current status of tissue regulation, procurement, processing, and sterilization.
McAllister DR; Joyce MJ; Mann BJ; Vangsness CT
Am J Sports Med; 2007 Dec; 35(12):2148-58. PubMed ID: 17974862
[TBL] [Abstract][Full Text] [Related]
12. Overview of safety issues concerning the preparation and processing of soft-tissue allografts.
Vangsness CT; Wagner PP; Moore TM; Roberts MR
Arthroscopy; 2006 Dec; 22(12):1351-8. PubMed ID: 17157736
[TBL] [Abstract][Full Text] [Related]
13. Clinical skin banking: a simplified system for processing, storage, and retrieval of human allografts.
Ninnemann JL; Fisher JC; Frank HA
J Trauma; 1978 Oct; 18(10):723-5. PubMed ID: 359825
[TBL] [Abstract][Full Text] [Related]
14. Can contamination of a patient's allograft be traced back to the allograft donor?
Neely AN; Plessinger RT; Stamper B; Kagan RJ
J Burn Care Res; 2008; 29(1):73-6. PubMed ID: 18182900
[TBL] [Abstract][Full Text] [Related]
15. Quality assessment and microbiologic screening of donor corneas.
Hassan SS; Wilhelmus KR
Cornea; 2007 Sep; 26(8):953-5. PubMed ID: 17721295
[TBL] [Abstract][Full Text] [Related]
16. Bacterial contamination of musculoskeletal allografts.
Maso A; Andollina A; Bassi A; Bertoni G; Modelli L; Quinto C; Vaccari M; Fornasari PM
Chir Organi Mov; 2003; 88(4):345-50. PubMed ID: 15259549
[TBL] [Abstract][Full Text] [Related]
17. Evolving practice of the Helsinki Skin Bank.
Lindford AJ; Frey I; Vuola J; Koljonen V
Int Wound J; 2010 Aug; 7(4):277-81. PubMed ID: 20492012
[TBL] [Abstract][Full Text] [Related]
18. Short- and long-term bacterial inhibiting effect of high concentrations of glycerol used in the preservation of skin allografts.
Saegeman VS; Ectors NL; Lismont D; Verduyckt B; Verhaegen J
Burns; 2008 Mar; 34(2):205-11. PubMed ID: 18037568
[TBL] [Abstract][Full Text] [Related]
19. Suspect the donor with potential infection in the adult deceased donor liver transplantation.
Wu TJ; Lee CF; Chou HS; Yu MC; Lee WC
Transplant Proc; 2008 Oct; 40(8):2486-8. PubMed ID: 18929774
[TBL] [Abstract][Full Text] [Related]
20. Donor age and cold ischemia interact to produce inferior 90-day liver allograft survival.
Reese PP; Sonawane SB; Thomasson A; Yeh H; Markmann JF
Transplantation; 2008 Jun; 85(12):1737-44. PubMed ID: 18580465
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
